Primary Record
iomeprol
- In stock
- 9,153 g
- Purity
- 99.8 %
- CAS
- 78649-41-9
Compound Identifiers & Properties
- CAS
- 78649-41-9
- PubChem CID
- 3731
- SMILES
- CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
- Canonical SMILES
- CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I
Names & Synonyms
- iomeprol
- Iomeron
- Iomeprolum
- Iomeprolo
- Imeron
- 78649-41-9
- iohexol
- Accudenz
- Exypaque
- Nycodenz
- Omnipaque
- Iomeprol-d3
- Iomeron 300
- Omnipaque R
- Iomeprol Injection
- IOMERVU
- iomeprol 350
- iomeprol 400
- Omnipaque 140
- Omnipaque 240
- Omnipaque 300
- Omnipaque 350
- Iomeprolum [INN-Latin]
- Iomervu (TN)
- Iomeron 350-d3
- IOMEPROL [USAN]
- RefChem:57671
- DTXSID1049061
- IOMEPROL [INN]
- IOMEPROL [JAN]
- IOMEPROL [MI]
- AC1Q4PBN
- Iomeron 300 (TN)
- 17E17JBP8L
- GlyTouCan:G06851GG
- UNII-17E17JBP8L
- IOMEPROL [MART.]
- D09RUW
- IOMEPROL [WHO-DD]
- AC1L1GL2
- AC1Q3VT9
- SCHEMBL26981
- DTXCID2028987
- Iomeprol (JAN/USAN/INN)
- CHEBI:31710
- Iomeprol [USAN:BAN:INN:JAN]
- Iomeprol [USAN:INN:BAN:JAN]
- orb2565958
- CHEMBL2107214
- CTK8G0335
- CID3731
- V08AB10
- NJKDOADNQSYQEV-UHFFFAOYSA-N
- E-7337
- BCP34386
- CID:3731
- G06851GG
- MSK10800
- Tox21_113611
- AR-1K1130
- EBC-27464
- MFCD00867961
- NCGC00183283-01
- E7337
- AKOS030255901
- 4-Methoxy-1H-pyrrolo[2,3-c]pyridine
- ACN-043399
- AN-5244
- AT46190
- C17-H22-I3-N3-O8
- DB11705
- AC-30722
- LS-29727
- SID:134224493
- CAS-78649-41-9
- DB-056324
- HY-150137
- Iomeprol 100 microg/mL in Acetonitrile/Methanol
- J277.762B
- N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(N-methylglycolamido)isophthalamide
- CS-0612179
- FT-0627277
- FT-0670399
- N1,N3-Bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-methylacetamido)-2,4,6-triiodoisophthalamide
- NS00000228
- D01719
- SBI-0654159.0001
- A839467
- B-16880
- C057937
- EN300-19767832
- 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- 1185146-41-1
- Q6062808
- N,N'-bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide
- 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)methylamino)-2,4,6-triiodo-
- N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-methylacetamido)-2,4,6-triiodobenzene-1,3-dicarboxamide
- N,N -Bis(2,3-dihydroxypropyl)-5-[methyl(hydroxyacetyl)amino]-2,4,6-triiodoisophthalamide
- N,N'-bis(2,3-dihydroxypropyl)-5-(glycoloyl(methyl)amino)-2,4,6-triiodoisophthalamide
- 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-
- 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)methylamino]-2,4,6-triiodo- (9CI); N1,N3-Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide; Imeron; Imeron 300; Iomeprol; Iomeron; Iomeron 350
- 5-[Acetyl(2,3-dihydroxypropyl)amino]-N,N inverted exclamation mark -bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
- 66108-95-0
- 83086-14-0
- N,N'-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
- N~1~,N~3~-Bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-methylacetamido)-2,4,6-triiodobenzene-1,3-dicarboxamide
- N1,N3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methyl-amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide
- N1,N3-Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide